Vision to become the world’s leading Medical devices / MedTech investorst
MCRA has become one of the world's leading Clinical Research Organizations (CROs) specializing in MedTech. The Company strategically taps into MCRA's clients, prioritizing those with strong clinical and commercial potential. The Companies founder has a unique investment strategy that has three primary themes tailored to maximize shareholder value: Venture (centred on disruptive technologies at the regulatory inflection points), Growth (focusing on revenue-generating companies that lead their respective categories), and Income (providing financing options like A/R factoring, instrument leasing, and royalties).
- Fundraising target of USD $100M
- Till date raised USD $18.8M
- Founders invested over USD $5M till date
- Founders have over three decades of investment management and operational experience in building MedTech companies
- Portfolio currently has 9 investments in thematic areas
- Strong track record with 20 successful exits that generated USD $2.8B with a 2.8x average return on investment (ROI) under 5.1 years
- Successfully made its first exit in August 2024, achieving an 83% IRR and a 2x return on capital